MyMitochondria wordmark with a teal mitochondrion icon and navy lettering

Science & Health Powering Your Cells

Latest edition · Mitochondrial medicine, translated without the hype
Research snapshot · Sep 26, 2026
Evidence desk

Medications

Approved and investigational medicines that act on mitochondrial disease or pathways.

Illustration of medicine capsules dissolving into a glowing cellular core
Custom illustration for the Medications desk.
Medications

FORZINITY and SS-31: approval limits

Elamipretide’s accelerated approval is limited to Barth syndrome and does not validate gray-market or broad anti-aging use.

Read article →

Site imagery: custom illustrations by MyMitochondria; stock photography via Pexels, Splitshire, StockCake and Vecteezy — illustrative only. Models pictured are not patients, clinicians, endorsers, or cases described in our articles.